Company
United StatesEmily A. DiMango, M.D., New York, NY – FDA Inspections
Inspection records and compliance data for Emily A. DiMango, M.D. in New York, New York. 2 FDA inspections on record, 1 Form 483, last inspected August 13, 2024.
Company Profile
This profile covers Emily A. DiMango, M.D. based in New York, New York, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 2
- NAI
- 0
- Form 483s
- 1
- Warning letters
- 0
First inspected October 2, 2017. Last inspected August 13, 2024.
Most cited issue areas
- FD-1572, protocol compliance1 inspection
- Safety Reports - Serious Events1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 13, 2024 | VAI | Human Drugs · Bioresearch Monitoring | 1246415 |
| October 2, 2017 | VAI | Human Drugs · Bioresearch Monitoring | 1027368 |
FDA documents
Form 483s (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Emily A. DiMango, M.D.
FEI Number
3013753808
Address
Columbia University Medical Center, 622 West 168th Street, New York, New York 10032, United States
Country
United States
ID: 67c89259-5c4d-4f1d-a3c9-f1ef059170e1